nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—parotid gland—head and neck cancer	0.0761	0.198	CbGeAlD
Icosapent ethyl—DGAT1—saliva-secreting gland—head and neck cancer	0.0729	0.19	CbGeAlD
Icosapent ethyl—DGAT1—connective tissue—head and neck cancer	0.067	0.175	CbGeAlD
Icosapent ethyl—DGAT1—trachea—head and neck cancer	0.0563	0.147	CbGeAlD
Icosapent ethyl—DGAT1—thyroid gland—head and neck cancer	0.0445	0.116	CbGeAlD
Icosapent ethyl—DGAT1—head—head and neck cancer	0.0395	0.103	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—head and neck cancer	0.0276	0.072	CbGeAlD
Icosapent ethyl—Dihomo-gamma-linolenic acid—PTGS2—head and neck cancer	0.0195	0.56	CrCbGaD
Icosapent ethyl—Sudden death—Fluorouracil—head and neck cancer	0.0179	0.031	CcSEcCtD
Icosapent ethyl—Icosapent—PTGS2—head and neck cancer	0.0153	0.44	CrCbGaD
Icosapent ethyl—Neoplasm—Vinblastine—head and neck cancer	0.0126	0.0218	CcSEcCtD
Icosapent ethyl—Neoplasm—Hydroxyurea—head and neck cancer	0.0115	0.0199	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0114	0.0197	CcSEcCtD
Icosapent ethyl—Polyp—Docetaxel—head and neck cancer	0.0109	0.0188	CcSEcCtD
Icosapent ethyl—Cyst—Docetaxel—head and neck cancer	0.0099	0.0171	CcSEcCtD
Icosapent ethyl—Intestinal obstruction—Docetaxel—head and neck cancer	0.00971	0.0168	CcSEcCtD
Icosapent ethyl—Angina pectoris—Vinblastine—head and neck cancer	0.00853	0.0148	CcSEcCtD
Icosapent ethyl—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00823	0.0142	CcSEcCtD
Icosapent ethyl—Pancreatitis—Hydroxyurea—head and neck cancer	0.00783	0.0136	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0077	0.0133	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Vinblastine—head and neck cancer	0.00766	0.0132	CcSEcCtD
Icosapent ethyl—Infestation NOS—Hydroxyurea—head and neck cancer	0.00712	0.0123	CcSEcCtD
Icosapent ethyl—Infestation—Hydroxyurea—head and neck cancer	0.00712	0.0123	CcSEcCtD
Icosapent ethyl—Pharyngitis—Vinblastine—head and neck cancer	0.00696	0.012	CcSEcCtD
Icosapent ethyl—Colitis—Docetaxel—head and neck cancer	0.00635	0.011	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Fluorouracil—head and neck cancer	0.00633	0.0109	CcSEcCtD
Icosapent ethyl—Fluid retention—Docetaxel—head and neck cancer	0.00628	0.0109	CcSEcCtD
Icosapent ethyl—Alopecia—Vinblastine—head and neck cancer	0.0062	0.0107	CcSEcCtD
Icosapent ethyl—Neoplasm—Docetaxel—head and neck cancer	0.00598	0.0103	CcSEcCtD
Icosapent ethyl—Dysphagia—Fluorouracil—head and neck cancer	0.00575	0.00995	CcSEcCtD
Icosapent ethyl—Chills—Hydroxyurea—head and neck cancer	0.00574	0.00993	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Vinblastine—head and neck cancer	0.00566	0.0098	CcSEcCtD
Icosapent ethyl—Alopecia—Hydroxyurea—head and neck cancer	0.00565	0.00978	CcSEcCtD
Icosapent ethyl—Angina pectoris—Fluorouracil—head and neck cancer	0.0056	0.00969	CcSEcCtD
Icosapent ethyl—Malaise—Vinblastine—head and neck cancer	0.0055	0.00952	CcSEcCtD
Icosapent ethyl—Vertigo—Vinblastine—head and neck cancer	0.00548	0.00949	CcSEcCtD
Icosapent ethyl—Hypertension—Vinblastine—head and neck cancer	0.00527	0.00912	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00517	0.00894	CcSEcCtD
Icosapent ethyl—Pneumonia—Fluorouracil—head and neck cancer	0.00516	0.00892	CcSEcCtD
Icosapent ethyl—Discomfort—Vinblastine—head and neck cancer	0.00513	0.00888	CcSEcCtD
Icosapent ethyl—Infestation—Fluorouracil—head and neck cancer	0.00513	0.00887	CcSEcCtD
Icosapent ethyl—Infestation NOS—Fluorouracil—head and neck cancer	0.00513	0.00887	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00505	0.00874	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Fluorouracil—head and neck cancer	0.00503	0.0087	CcSEcCtD
Icosapent ethyl—Malaise—Hydroxyurea—head and neck cancer	0.00502	0.00869	CcSEcCtD
Icosapent ethyl—Epistaxis—Fluorouracil—head and neck cancer	0.00484	0.00837	CcSEcCtD
Icosapent ethyl—Sinusitis—Fluorouracil—head and neck cancer	0.00481	0.00832	CcSEcCtD
Icosapent ethyl—Anorexia—Vinblastine—head and neck cancer	0.00475	0.00822	CcSEcCtD
Icosapent ethyl—Migraine—Docetaxel—head and neck cancer	0.00473	0.00818	CcSEcCtD
Icosapent ethyl—Discomfort—Hydroxyurea—head and neck cancer	0.00468	0.0081	CcSEcCtD
Icosapent ethyl—Rhinitis—Fluorouracil—head and neck cancer	0.00461	0.00798	CcSEcCtD
Icosapent ethyl—Pharyngitis—Fluorouracil—head and neck cancer	0.00457	0.0079	CcSEcCtD
Icosapent ethyl—Oedema—Hydroxyurea—head and neck cancer	0.00454	0.00786	CcSEcCtD
Icosapent ethyl—Infection—Hydroxyurea—head and neck cancer	0.00451	0.00781	CcSEcCtD
Icosapent ethyl—Anorexia—Hydroxyurea—head and neck cancer	0.00433	0.00749	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vinblastine—head and neck cancer	0.00433	0.00749	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00432	0.00748	CcSEcCtD
Icosapent ethyl—Pain—Vinblastine—head and neck cancer	0.00426	0.00737	CcSEcCtD
Icosapent ethyl—Constipation—Vinblastine—head and neck cancer	0.00426	0.00737	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00424	0.00733	CcSEcCtD
Icosapent ethyl—Dysphagia—Docetaxel—head and neck cancer	0.00415	0.00718	CcSEcCtD
Icosapent ethyl—Arrhythmia—Fluorouracil—head and neck cancer	0.00411	0.00711	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Vinblastine—head and neck cancer	0.00411	0.0071	CcSEcCtD
Icosapent ethyl—Alopecia—Fluorouracil—head and neck cancer	0.00407	0.00704	CcSEcCtD
Icosapent ethyl—Dyspnoea—Hydroxyurea—head and neck cancer	0.00405	0.00701	CcSEcCtD
Icosapent ethyl—Angina pectoris—Docetaxel—head and neck cancer	0.00404	0.00699	CcSEcCtD
Icosapent ethyl—Dyspepsia—Hydroxyurea—head and neck cancer	0.004	0.00692	CcSEcCtD
Icosapent ethyl—Decreased appetite—Hydroxyurea—head and neck cancer	0.00395	0.00683	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00392	0.00679	CcSEcCtD
Icosapent ethyl—Pain—Hydroxyurea—head and neck cancer	0.00389	0.00672	CcSEcCtD
Icosapent ethyl—Constipation—Hydroxyurea—head and neck cancer	0.00389	0.00672	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00374	0.00648	CcSEcCtD
Icosapent ethyl—Pneumonia—Docetaxel—head and neck cancer	0.00372	0.00644	CcSEcCtD
Icosapent ethyl—Infestation NOS—Docetaxel—head and neck cancer	0.0037	0.0064	CcSEcCtD
Icosapent ethyl—Infestation—Docetaxel—head and neck cancer	0.0037	0.0064	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00365	0.00631	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Docetaxel—head and neck cancer	0.00363	0.00628	CcSEcCtD
Icosapent ethyl—Body temperature increased—Hydroxyurea—head and neck cancer	0.00359	0.00621	CcSEcCtD
Icosapent ethyl—Asthenia—Vinblastine—head and neck cancer	0.00357	0.00618	CcSEcCtD
Icosapent ethyl—Epistaxis—Docetaxel—head and neck cancer	0.00349	0.00604	CcSEcCtD
Icosapent ethyl—Chest pain—Fluorouracil—head and neck cancer	0.00341	0.0059	CcSEcCtD
Icosapent ethyl—Myalgia—Fluorouracil—head and neck cancer	0.00341	0.0059	CcSEcCtD
Icosapent ethyl—Discomfort—Fluorouracil—head and neck cancer	0.00337	0.00583	CcSEcCtD
Icosapent ethyl—Rhinitis—Docetaxel—head and neck cancer	0.00333	0.00576	CcSEcCtD
Icosapent ethyl—Pharyngitis—Docetaxel—head and neck cancer	0.0033	0.0057	CcSEcCtD
Icosapent ethyl—Dizziness—Vinblastine—head and neck cancer	0.00329	0.0057	CcSEcCtD
Icosapent ethyl—Oedema—Fluorouracil—head and neck cancer	0.00327	0.00566	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00327	0.00566	CcSEcCtD
Icosapent ethyl—Asthenia—Hydroxyurea—head and neck cancer	0.00326	0.00564	CcSEcCtD
Icosapent ethyl—Infection—Fluorouracil—head and neck cancer	0.00325	0.00562	CcSEcCtD
Icosapent ethyl—Tachycardia—Fluorouracil—head and neck cancer	0.00319	0.00552	CcSEcCtD
Icosapent ethyl—Vomiting—Vinblastine—head and neck cancer	0.00317	0.00548	CcSEcCtD
Icosapent ethyl—Anorexia—Fluorouracil—head and neck cancer	0.00312	0.00539	CcSEcCtD
Icosapent ethyl—Dizziness—Hydroxyurea—head and neck cancer	0.003	0.0052	CcSEcCtD
Icosapent ethyl—Chills—Docetaxel—head and neck cancer	0.00298	0.00516	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00298	0.00515	CcSEcCtD
Icosapent ethyl—Arrhythmia—Docetaxel—head and neck cancer	0.00297	0.00513	CcSEcCtD
Icosapent ethyl—Insomnia—Fluorouracil—head and neck cancer	0.00296	0.00512	CcSEcCtD
Icosapent ethyl—Alopecia—Docetaxel—head and neck cancer	0.00294	0.00508	CcSEcCtD
Icosapent ethyl—Dyspnoea—Fluorouracil—head and neck cancer	0.00292	0.00504	CcSEcCtD
Icosapent ethyl—Malnutrition—Docetaxel—head and neck cancer	0.00289	0.005	CcSEcCtD
Icosapent ethyl—Vomiting—Hydroxyurea—head and neck cancer	0.00289	0.005	CcSEcCtD
Icosapent ethyl—Dyspepsia—Fluorouracil—head and neck cancer	0.00288	0.00498	CcSEcCtD
Icosapent ethyl—Rash—Hydroxyurea—head and neck cancer	0.00286	0.00496	CcSEcCtD
Icosapent ethyl—Dermatitis—Hydroxyurea—head and neck cancer	0.00286	0.00495	CcSEcCtD
Icosapent ethyl—Decreased appetite—Fluorouracil—head and neck cancer	0.00284	0.00492	CcSEcCtD
Icosapent ethyl—Dysgeusia—Docetaxel—head and neck cancer	0.00283	0.0049	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00282	0.00488	CcSEcCtD
Icosapent ethyl—Back pain—Docetaxel—head and neck cancer	0.0028	0.00484	CcSEcCtD
Icosapent ethyl—Pain—Fluorouracil—head and neck cancer	0.0028	0.00484	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Fluorouracil—head and neck cancer	0.00269	0.00466	CcSEcCtD
Icosapent ethyl—Syncope—Docetaxel—head and neck cancer	0.00259	0.00449	CcSEcCtD
Icosapent ethyl—Body temperature increased—Fluorouracil—head and neck cancer	0.00259	0.00447	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Docetaxel—head and neck cancer	0.00254	0.0044	CcSEcCtD
Icosapent ethyl—Cough—Docetaxel—head and neck cancer	0.00252	0.00437	CcSEcCtD
Icosapent ethyl—Hypertension—Docetaxel—head and neck cancer	0.0025	0.00432	CcSEcCtD
Icosapent ethyl—Myalgia—Docetaxel—head and neck cancer	0.00246	0.00426	CcSEcCtD
Icosapent ethyl—Arthralgia—Docetaxel—head and neck cancer	0.00246	0.00426	CcSEcCtD
Icosapent ethyl—Chest pain—Docetaxel—head and neck cancer	0.00246	0.00426	CcSEcCtD
Icosapent ethyl—Dry mouth—Docetaxel—head and neck cancer	0.00241	0.00417	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Docetaxel—head and neck cancer	0.00236	0.00408	CcSEcCtD
Icosapent ethyl—Oedema—Docetaxel—head and neck cancer	0.00236	0.00408	CcSEcCtD
Icosapent ethyl—Infection—Docetaxel—head and neck cancer	0.00234	0.00406	CcSEcCtD
Icosapent ethyl—Shock—Docetaxel—head and neck cancer	0.00232	0.00402	CcSEcCtD
Icosapent ethyl—Pruritus—Fluorouracil—head and neck cancer	0.00231	0.004	CcSEcCtD
Icosapent ethyl—Tachycardia—Docetaxel—head and neck cancer	0.0023	0.00399	CcSEcCtD
Icosapent ethyl—Anorexia—Docetaxel—head and neck cancer	0.00225	0.00389	CcSEcCtD
Icosapent ethyl—Dizziness—Fluorouracil—head and neck cancer	0.00216	0.00374	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00215	0.00372	CcSEcCtD
Icosapent ethyl—Insomnia—Docetaxel—head and neck cancer	0.00213	0.00369	CcSEcCtD
Icosapent ethyl—Dyspnoea—Docetaxel—head and neck cancer	0.0021	0.00364	CcSEcCtD
Icosapent ethyl—Vomiting—Fluorouracil—head and neck cancer	0.00208	0.0036	CcSEcCtD
Icosapent ethyl—Dyspepsia—Docetaxel—head and neck cancer	0.00208	0.00359	CcSEcCtD
Icosapent ethyl—Rash—Fluorouracil—head and neck cancer	0.00206	0.00357	CcSEcCtD
Icosapent ethyl—Dermatitis—Fluorouracil—head and neck cancer	0.00206	0.00356	CcSEcCtD
Icosapent ethyl—Decreased appetite—Docetaxel—head and neck cancer	0.00205	0.00355	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00204	0.00353	CcSEcCtD
Icosapent ethyl—Pain—Docetaxel—head and neck cancer	0.00202	0.00349	CcSEcCtD
Icosapent ethyl—Constipation—Docetaxel—head and neck cancer	0.00202	0.00349	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Docetaxel—head and neck cancer	0.00195	0.00337	CcSEcCtD
Icosapent ethyl—Body temperature increased—Docetaxel—head and neck cancer	0.00187	0.00323	CcSEcCtD
Icosapent ethyl—Asthenia—Docetaxel—head and neck cancer	0.00169	0.00293	CcSEcCtD
Icosapent ethyl—Pruritus—Docetaxel—head and neck cancer	0.00167	0.00289	CcSEcCtD
Icosapent ethyl—Dizziness—Docetaxel—head and neck cancer	0.00156	0.0027	CcSEcCtD
Icosapent ethyl—Vomiting—Docetaxel—head and neck cancer	0.0015	0.0026	CcSEcCtD
Icosapent ethyl—Rash—Docetaxel—head and neck cancer	0.00149	0.00257	CcSEcCtD
Icosapent ethyl—Dermatitis—Docetaxel—head and neck cancer	0.00149	0.00257	CcSEcCtD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—RARB—head and neck cancer	0.00121	0.374	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000349	0.108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Vitamin A and Carotenoid Metabolism—MAPK1—head and neck cancer	0.00026	0.0807	CbGpPWpGaD
Icosapent ethyl—DGAT1—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000196	0.0609	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—UROD—head and neck cancer	0.000179	0.0555	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000139	0.0431	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PTEN—head and neck cancer	0.000126	0.0391	CbGpPWpGaD
Icosapent ethyl—DGAT1—Phospholipid metabolism—PIK3CA—head and neck cancer	8.88e-05	0.0276	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.89e-05	0.0245	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.81e-05	0.0242	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—NAT2—head and neck cancer	7.43e-05	0.0231	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—DPYD—head and neck cancer	6.52e-05	0.0202	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—YAP1—head and neck cancer	6.18e-05	0.0192	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.65e-05	0.0144	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.05e-05	0.0126	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—TYMS—head and neck cancer	3.71e-05	0.0115	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GSTM1—head and neck cancer	3.67e-05	0.0114	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—GPX1—head and neck cancer	3.52e-05	0.0109	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—CYP1A1—head and neck cancer	3.48e-05	0.0108	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.86e-05	0.00887	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTGS2—head and neck cancer	2.07e-05	0.00642	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PTEN—head and neck cancer	1.8e-05	0.0056	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—PIK3CA—head and neck cancer	1.27e-05	0.00395	CbGpPWpGaD
Icosapent ethyl—DGAT1—Metabolism—AKT1—head and neck cancer	1.04e-05	0.00323	CbGpPWpGaD
